Project Grant R34CA287720
Award Date
9/4/24
Completion Date
6/30/27
Dollars Obligated
$257K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14214, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $1,003,164 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Yale University to evaluate the feasibility and efficacy of a smartphone-based cognitive-behavioral therapy (CBT) app, called "Kick-NIC!," for supporting e-cigarette cessation among adolescents. The 5-year grant, beginning September 1, 2024, will fund a randomized controlled trial to assess the app's impact on reducing e-cigarette use among 306 high school...
This $565,181 Project Grant, awarded by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) to the University of Rochester, aims to identify key features of e-cigarette-related social media posts associated with high user engagement. The project will apply advanced artificial intelligence and statistical modeling techniques to characterize features of posts on Twitter/X, Instagram, TikTok, and YouTube that drive high engagement, such as retweets and likes. The...
This Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, is for a $1,698,536 behavioral and digital intervention study to promote vaping cessation and prevent escalation of tobacco use among adolescents aged 14-18. The Primary Awardee, The General Hospital Corporation (Massachusetts General Hospital), will evaluate the effectiveness of the "QuitVaping" intervention, a fully remote, 12-session...
This federal Project Grant award, provided by the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), supports a mixed-methods study to develop a motivation-based typology of adolescent e-cigarette users. The $310,319 award, spanning September 2024 to August 2027, will enable researchers at the University of Louisville to gather formative data on different types of adolescent e-cigarette users based on their motivations for use. This information...
The National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Regents of the University of California, San Francisco (UCSF) in the amount of $692,872.00, with a project period of September 9, 2024 to August 31, 2029. The grant funding supports the development and evaluation of a scalable social media-based vaping cessation program, "Quit the Hit Toolkit", to help address the rising rates...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $687,995 to Yale University to conduct a randomized clinical trial investigating the efficacy of varenicline for cessation of e-cigarette use among adults. The study aims to: 1) Compare e-cigarette quit rates between varenicline and placebo treatments, 2) Identify predictors and moderators of treatment response, and 3) Explore changes in...
The National Cancer Institute (NCI) awarded a $279,573 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Houston System to refine and test a novel smoking cessation intervention that integrates olfactory stimulation to reduce cigarette cravings with an established smartphone-based smoking cessation application. The project aims to (1) refine the design and methodology for the olfactory stimulation delivery system and (2) determine the adjunctive benefit...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $619,175 to The Medical University of South Carolina to conduct a randomized controlled trial exploring the use of e-cigarettes as a harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The 5-year study (12/1/2024 - 11/30/2029) aims to evaluate rates of complete switching from cigarettes to e-cigarettes, as well as...
The National Cancer Institute (NCI) awarded a $247,433 Project Grant (R34CA287719) under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Nebraska Medical Center to develop and pilot test a "Parents Helping Parents for Youth Vaping Cessation (PHP-VX)" program. The goal is to provide a parent-facilitated vaping cessation intervention for older adolescents aged 15-18, who have the highest rates of e-cigarette use. The study will partner with the...
This $316,873 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will enable the development and pilot testing of a smartphone app version of the Libre del Cigarrillo smoking cessation intervention for Spanish-speaking smokers. The Libre del Cigarrillo intervention was previously validated in a nationwide randomized controlled trial, demonstrating high efficacy compared to usual care. This project aims to adapt the...